6】报告题目       国际疾病非药物干预科学应用联盟赋能健康中国 2030 建设

                                      第二届食药物质健康中国国际高峰论坛

                               暨"菩惠宁"癌瘤非药物干预产品功效认证新闻发布会

                    国际疾病非药物干预科学应用联盟（中国代表处）执行秘书长 吴玲

摘   要：

《“健康中国 2030”规划纲要》“以人民健康为中心”的根本性转变，规范化的疾病非药物干预成为

补齐公共卫生短板、降低社会疾病负担、提升国民健康水平的关键举措

关键词：纵观世界各国疾病以药物治疗为主的医疗模式，已难以满足民众全生命周期的健康需求

论   述：

国际疾病非药物干预科学应用联盟是由国务院发展研究中心（中欧一带一路饮食营养与健康专家委员会），联合国妇女儿童基金会，上海食文化研究会营养与药食同源专委会，国际食药物质与健康产业联盟，中国营养与医疗健康有限公司（香港），香港医院管理局，香港大学中医药学院，法国生物科技，美国医疗门诊连锁机构共同发起 ，2025 年 10 月 19 日在法国巴黎成立。

《“健康中国 2030”规划纲要》明确提出中国卫生健康事业要实现从“以治病为中心”向“以人民健康为中心”的根本性转变，确立了“预防为主、医防融合、全民共建共享”的核心发展方针。当前，中国人口老龄化进程加快，慢性病高发多发、亚健康群体规模庞大，传统以药物治疗为主的医疗临床模式，已难以满足全人群、全生命周期的现代化健康需求。在此背景下，科学化、系统化、规范化的疾病非药物干预成为补齐公共卫生短板、降低社会疾病负担、提升国民健康水平的关键可行举措。

国际疾病非药物干预科学应用联盟作为全球专注疾病非药物干预领域的权威国际合作平台，立足全球视野、紧扣国家战略，通过科研协同、标准共建、产业赋能、国际交流等多元举措，为健康中国 2030 战略实施提供重要支撑与强大动能。现阶段，慢性病已成为影响我国国民健康的首要因素，慢性病死亡占总死亡人数的 88%以上，疾病负担占比超 70%，严重制约全民健康目标推进。长期以来，我国健康治理存在“重治疗、轻预防、重药物、轻干预、重经验、轻科学”的结构性问题，非药物干预领域普遍存在科学循证不足、行业标准缺失、成果转化率低、产业发展不规范、国际话语权薄弱等突出短板。国际疾病非药物干预科学应用联盟的成立与发展，顺应全球公共卫生发展趋势，契合国家健康战略布局，对推动我国卫生健康事业高质量发展具有重要现实意义与战略价值。

核心宗旨：国际疾病非药物干预科学应用联盟是集学术研究、标准制定、产业转化、国际合作为一体的全球性专业平台。联盟汇聚全球多个国家和地区的高校科研院所、医疗机构、行业专家及健康产业主体，以推动疾病非药物干预科学化、标准化、产业化、国际化发展为核心使命。

总   结：

健康中国 2030 将壮大健康产业作为重要战略任务，国际疾病非药物干预科学应用联盟将依托全球健康产业资源渠道，疏解国内外技术互通、产品互认、市场互联通道，推动以中国食文化为底蕴，关注餐桌上的药膳食疗，结合现代科学精准营养、智慧康养、以饮食作为健康管理的第一动能，完善功能性健康产品等新业态规范化、品牌化、国际化发展，推动饮食文化与营养健康产业向科技化、标准化高质量转型，持续释放大健康产业经济动能。联盟充分发挥国际化平台优势，积极向全球推介中国预防医学经验、药食同源健康理念和慢病治理模式，打破单一西方医疗话语体系，为全球慢性病非药物干预贡献中国食文化与餐桌上健康智慧，最好的医院是厨房、最好的医生是自己。

6】Report topic:The International Alliance for Disease Non-Drug Intervention Science and Application Empowers theConstruction of a Healthy China 2030

The 2nd China International Summit Forum on Food and Drug Quality Health

Press conference on efficacy certification of "Puhuining" cancer tumour non-drug intervention products

International Alliance for Disease Non-Drug Intervention Science Application (China Representative Office)

Executive Secretary-General Ling Wu

Abstract：The fundamental transformation of "People's Health-centred" in the "Healthy China 2030" Planning Outline,

standardised non-drug intervention for diseases has become a key measure to make up for the shortcomings of public

health, reduce the burden of social diseases, and improve the health level of the people.

Keyword：Looking at the medical model based on drug treatment for diseases in countries around the world, it is difficult to meet the health needs of the people throughout the life cycle.

Expound：The International Alliance for Disease Non-Drug Intervention Science Application was jointly launched by he Development Research Centre of the State Council (China-Europe Belt and Road Diet, Nutrition and Health Expert Committee), the United Nations Women's and Children's Fund, the Special Committee on Nutrition and Medicine of the Shanghai Food Culture Research Association, the International Alliance for Food and Drug Quality and Health Industry, China Nutrition and Medical Health Co., Ltd. (Hong Kong), the Hong Kong Hospital Authority,

the School of Traditional Chinese Medicine of the University of Hong Kong, the French Biotechnology, and the American medical outpatient chain.The "Healthy China 2030" Planning Outline clearly puts forward that China's health undertakings should realise the fundamental transformation from "disease-centred" to "people's health-centred",

and establishes the core development policy of "prevention-oriented, medical and prevention integration, and national joint construction and sharing". At present, the ageing process of China's population is accelerating, the incidence of hronic diseases is high, and the scale of sub-health groups is huge. The traditional medical clinical model based on drug treatment is difficult to meet the modern health needs of the whole population and the whole lifecycle.Against this background, scientific, systematic and standardised non-drug intervention for diseases has become a key and  feasible measure to make up for the shortcomings of public health, reduce the burden of social diseases and improve

national health. As an authoritative international cooperation platform focussing on the field of disease non-drug intervention in the world, the International Disease Non-Drug Intervention Science Application Alliance provides important support for the implementation of the Healthy China 2030 strategy through diversified measures such as scientific research coordination, standard co-construction, industrial empowerment and international exchanges based

on the global vision and closely following the national strategy. And powerful kinetic energy. At present, chronic diseases have become the primary factor affecting China's national health. Deaths from chronic diseases account for more than 88% of the total number of deaths, and the burden of diseases accounts for more than 70%, which seriously restricts the promotion of national health goals.For a long time, China's health governance has had structural

problems of "heavy treatment, neglecting prevention, emphasising drugs, neglecting intervention, emphasising

experience, neglecting science". In the field of non-drug intervention, there are widespread shortcomings such as insufficient scientific evidence, lack of industry standards, low conversion rate of achievements, non-standardised  industrial development, and weak international discourse. The establishment and development of the International

Alliance for Non-Drug Intervention Science and Application of Diseases is in line with the development trend of  global public health and the layout of the national health strategy. It is of great practical significance and strategic value

for promoting the high-quality development of China's health industry.

Core Purpose：The International Alliance for Disease Non-Drug Intervention Science Application is a global  professional platform integrating academic research, standard setting, industrial transformation and international  cooperation. The alliance brings together scientific research institutes, medical institutions, industry experts and health industry entities from many countries and regions around the world, with the core mission of promoting the scientific,

standardised, industrial and international development of non-drug intervention in diseases.

Conclusion： Healthy China 2030 will take the expansion of the health industry as an important strategic task. The International Disease Non-Drug Intervention Science and Application Alliance will rely on the global health industry resource channels to relieve domestic and foreign technology interoperability, product mutual recognition and market

interconnection channels, promote Chinese food culture as the background, pay attention to medicinal diet therapy on the table, and combine Modern scientific and precise nutrition, intelligent health care, taking diet as the first driving

force of health management, improving the standardisation, branding and internationalisation of new business forms such as functional health products, promoting the transformation of food culture and nutrition and health industry to science and technology, standardisation and high quality, and continuously releasing the economic momentum of the large health industry. The alliance gives full play to the advantages of the international platform, actively promotes

China's preventive medicine experience, the concept of medicine and food homology health and the chronic disease reatment model to the world, breaks the single Western medical discourse system, and contributes Chinese food culture and table health wisdom to the global non-drug intervention of chronic diseases. The best hospital is the  kitchen and the best doctor. It's myself.

编辑：食药物质国际交流栏目组  愚晏

翻译：国际食药物质与健康产业联盟 执行秘书长 孙丽

校对：国际疾病非药物干预科学应用联盟（中国代表处）执行秘书长 吴玲